Get the Stockscreener App
55.75
0.80%
0.44
After Hours:
55.77
0.02
+0.04%
Prestige Consumer Healthcare Inc stock is traded at $55.75, with a volume of 550.09K.
It is up +0.80% in the last 24 hours and up +6.23% over the past month.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
See More
Previous Close:
$55.31
Open:
$55.32
24h Volume:
550.09K
Relative Volume:
1.12
Market Cap:
$2.64B
Revenue:
$1.10B
Net Income/Loss:
$186.50M
P/E Ratio:
14.74
EPS:
3.7817
Net Cash Flow:
$267.19M
1W Performance:
-5.11%
1M Performance:
+6.23%
6M Performance:
-6.82%
1Y Performance:
-32.82%
1-Day Range:
$55.16
$56.59
1-Week Range:
$54.29
$58.94
52-Week Range:
$51.24
$89.37
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Name
Prestige Consumer Healthcare Inc
Sector
Phone
(914) 524-6800
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, ZTS, TEVA, HLN, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
55.75 | 2.62B | 1.10B | 186.50M | 267.19M | 3.7817 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Upgrade | Sidoti | Neutral → Buy |
| Dec-09-24 | Downgrade | Sidoti | Buy → Neutral |
| Jun-21-24 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-17-22 | Initiated | Canaccord Genuity | Buy |
| May-10-22 | Upgrade | Jefferies | Hold → Buy |
| May-09-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-07-20 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-29-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-14-20 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-20 | Resumed | Sidoti | Neutral |
| Mar-26-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-24-20 | Initiated | Oppenheimer | Perform |
| Mar-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-04-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jun-02-17 | Upgrade | Jefferies | Underperform → Hold |
| May-22-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-27-16 | Reiterated | B. Riley & Co. | Buy |
| Nov-17-16 | Initiated | Gabelli & Co | Buy |
| Aug-12-16 | Upgrade | Sidoti | Neutral → Buy |
| Mar-08-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Feb-05-16 | Initiated | Piper Jaffray | Overweight |
| Nov-30-15 | Downgrade | Jefferies | Hold → Underperform |
| Apr-28-14 | Reiterated | B. Riley & Co. | Buy |
| Apr-28-14 | Reiterated | Oppenheimer | Outperform |
| Jul-09-13 | Initiated | B. Riley & Co. | Buy |
View All
Prestige Consumer Healthcare Inc Stock (PBH) Latest News
Prestige (NYSE: PBH) CFO & COO reports tax-related share withholding - Stock Titan
Prestige Consumer (PBH) executive logs 432-share tax-withholding transaction - Stock Titan
Prestige Consumer (NYSE: PBH) CEO has shares withheld for taxes - Stock Titan
[Form 4] Prestige Consumer Healthcare Inc. Insider Trading Activity - Stock Titan
Prestige Consumer (PBH) officer logs 599-share tax withholding and 22,175-share holding - Stock Titan
PBH (NYSE: PBH) files Rule 144 notice for 346 shares - Stock Titan
(PBH) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Jennison Associates LLC Sells 42,539 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc. (NYSE:PBH) Short Interest Update - MarketBeat
Vanguard Capital Management (NYSE: PBH) reports 5.18% ownership of PBH - Stock Titan
Prestige Consumer sets May 14 call after fiscal 2026 results - Stock Titan
Prestige Consumer Healthcare Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
PBH Stock Price, Quote & Chart | PRESTIGE CONSUMER HEALTHCARE (NYSE:PBH) - ChartMill
Prestige Consumer Health to acquire Breathe Right for $1.045B - MSN
Prestige Consumer Healthcare Drops 6.9% Amid Sector-Wide Selling - AlphaStreet
Prestige Consumer Healthcare Inc (PBH) Shares Fall 4.7% -- What GF Score of 75 Tells Investors - GuruFocus
Vanguard Portfolio Management reports 5.97% stake in Prestige (PBH) - Stock Titan
Prestige Consumer Healthcare earnings on deck amid consumer test By Investing.com - Investing.com India
Prestige Consumer Healthcare earnings on deck amid consumer test - Investing.com
MSN - MSN
M&T Bank Corp Purchases 52,458 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Impax Asset Management Group plc Purchases 20,000 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige bets $1 billion on world's most iconic nasal strip - MSN
Prestige Consumer Healthcare to buy Breathe Right, other brands for $1.045 billion - MSN
National Advertising Division Finds Certain Eosera Ear Wax MD Claims Supported; Recommends Others Be Modified or Discontinued - The Manila Times
National Advertising Division Finds Certain Eosera Ear Wax - GlobeNewswire
Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Boston Trust Walden Corp Cuts Stake in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Responsive Playbooks and the PBH Inflection - Stock Traders Daily
Which Stocks Like Prestige (PBH) (Marginal Gain) 2026-04-20Social Investment Platform - Cổng thông tin điện tử Tỉnh Sơn La
Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring A Potential 35% Upside - DirectorsTalk Interviews
Revenue per share of Prestige Consumer Healthcare Inc – FWB:PBV - TradingView
Tributary Capital Management LLC Buys 33,832 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Small-Cap Value Fund's Prestige Consumer Healthcare Inc(PBH) Holding History - GuruFocus
Prestige (PBH) Stock: Resistance Levels (Underperforming) 2026-04-16Stock Analysis Community - Cổng thông tin điện tử tỉnh Tây Ninh
Massachusetts Financial Services Co. MA Has $40.15 Million Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
3 Undervalued Pharmaceuticals Stocks for Tuesday, April 14 - AAII.com
Aug Highlights: Will Prestige Consumer Healthcare Inc benefit from AI trendsIPO Watch & Community Verified Swing Trade Signals - baoquankhu1.vn
Prestige Consumer Healthcare (PBH) Stock Analysis: Is a 38.82% Upside Potential on the Horizon? - DirectorsTalk Interviews
Understanding the Setup: (PBH) and Scalable Risk - Stock Traders Daily
How does currency impact Prestige (PBH) Stock | PBH Q4 Earnings: Misses Estimates by $0.02Community Driven Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai
Why Prestige Consumer Healthcare (PBH) Is Down 5.8% After Heightened Regulatory Scrutiny On Its OTC Portfolio - Sahm
Prestige Consumer Healthcare Takes Deep International Breath With Breathe Right Deal - Citeline News & Insights
Prestige Consumer Healthcare Inc. (PBH) stock price, news, quote and history - Yahoo Finance Singapore
Has Prestige Consumer Healthcare (PBH) Fallen Too Far After Its 32% One-Year Share Price Drop - Yahoo Finance
Panic Selling: Can Prestige Consumer Healthcare Inc continue delivering strong returns2026 Catalysts & Long-Term Growth Plans - baoquankhu1.vn
Prestige Consumer Healthcare narrows fiscal 2026 revenue outlook to $1.1B while advancing Clear Eyes supply recovery - MSN
Prestige Consumer Healthcare (PBH) Is Down 10.3% After Rising FTC Scrutiny and Bearish SignalsWhat's Changed - Yahoo Finance
Is Prestige (PBH) Stock Declining | Price at $53.31, Up 1.58%Professional Trade Ideas - Xã Vĩnh Công
PBH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Prestige Consumer Healthcare Inc (PBH) Trading Down 6.76% on Apr 2 - GuruFocus
Prestige Consumer Healthcare Inc Stock (PBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
2.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):